Table 2 VZV level prior to zoster diagnosis subgroup analysis
Mean index value/OD (n) | SD | T-test | |
|---|---|---|---|
On ART at second serum | |||
No | 2.26 (119) | 0.89 | − 2.08* |
Yes | 2.48 (180) | 0.93 | − 2.08* |
Duration of HIV infection at second serum (years) | |||
< 7 | 2.38 (153) | 0.95 | − 0.30 |
7+ | 2.41 (146) | 0.89 | − 0.30 |
Viral load at second serum (log10 copies/mL) | |||
< 400 | 2.41 (127) | 0.87 | 0.20 |
400+ | 2.38 (170) | 0.95 | 0.20 |
CD4 at second serum (cells/μL) | |||
< 500 | 2.42 (149) | 0.97 | 0.56 |
500+ | 2.36 (149) | 0.87 | 0.56 |
CD4 at HIV diagnosis (cells/μL) | |||
< 500 | 2.45 (111) | 0.88 | 0.90 |
500+ | 2.34 (157) | 0.97 | 0.90 |
Age at HIV diagnosis (years) | |||
< 30 | 2.40 (174) | 0.98 | 0.09 |
30+ | 2.39 (125) | 0.82 | 0.09 |
Age at VZV infection (years) | |||
< 40 | 2.27 (59) | 0.97 | 0.32 |
40+ | 2.22 (40) | 0.65 | 0.32 |